Abstract
BackgroundSmoking is a negative predictor of response to antirheumatic therapy.ObjectivesTo assess whether smoking influence the response to rituximab (RTX) in Rheumatoid Arthritis (RA).MethodsPooled data from the Collaborating European Registries for...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
